StockWatch
·
 Medicinal Chemicals and Botanical Products
Quarterly ResultMay 12, 2026, 04:48 PM

Upexi Reports Q3 Net Loss of $109.3M; Equity Turns Negative

AI Summary

Upexi, Inc. reported a significant net loss of $109.3 million for the three months ended March 31, 2026, a substantial increase from $3.8 million in the prior year, primarily due to massive unrealized losses on digital assets. The company's total stockholders' equity turned negative, reaching $(51.9) million, down from $90.1 million. This quarter reflects the company's strategic shift to a Solana-focused digital asset treasury, which also led to substantial increases in digital asset holdings and convertible debt.

Key Highlights

  • Net loss for Q3 2026 was $(109.3) million, up from $(3.8) million in Q3 2025.
  • Net loss for nine months ended March 31, 2026, was $(221.5) million, up from $(6.8) million.
  • Total stockholders' equity became negative at $(51.9) million as of March 31, 2026.
  • Unrealized loss on digital assets for Q3 2026 was $92.3 million, significantly higher than Q3 2025.
  • Total digital assets (current and non-current) increased to $184.9 million.
  • Convertible notes payable increased to $181.0 million as of March 31, 2026, from $0.
  • The company recorded a $1.4 million impairment on assets from manufacturing shutdown.
  • Net cash used in operating activities for nine months increased to $(17.2) million.